Indications: combined therapy for cardiovascular diseases, during the recovery period after cerebrovascular disorders, head trauma, in the event of acute and chronic ischaemic cerebrovascular disorders; decreased work capacity; physical and psycho-emotional overload (for capsule form)
Meldonium Olainfarm anti-ischaemic medicinal product of metabolic action – structural analogue of carnitine precursor gamma-butyrobetaine, in which one of the carbon atoms has been replaced by a nitrogen atom. It decreases the biosynthesis of carnitine, thus inhibiting the transport of long chain fatty acids through cell membranes and preventing the accumulation of non-oxidised forms of fatty acids in cells.
500 – 1000 mg per day. The duration of use depends on indications. See the summary of product characteristics for more detailed information.
Solution for injections:
In the form of 5 – 10 ml intravenous injections once per day, recommended to use during the first half of the day. See the summary of product characteristics for more detailed information.
Not recommended for children under 18 years of age.